After identifying tumor-specific mutations, several in silico peptide prediction algorithms are applied to filter the neoantigen candidates in terms of their binding capacity to MHC molecules (https://www.iedb.org/ (accessed on 1 December 2021)). This evidence concerns the gene HLA-C and neoplasm.